Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Nov 28, 2011

30071_dirs_2011-11-28_b6d86e47-687f-49f2-bb27-583960814e28.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-23

Reporting Person: Jacobsen Stein (President - Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-23 ResMed Common Stock S 9195.964 $25.275 Disposed 52143.000 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices rangining from $25.26 to $25.30. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.